Post job

Decibel Therapeutics's revenue is $8.5 million.

What is Decibel Therapeutics's revenue?

Decibel Therapeutics's annual revenue is $8.5M. Zippia's data science team found the following key financial metrics about Decibel Therapeutics after extensive research and analysis.
  • Decibel Therapeutics has 61 employees, and the revenue per employee ratio is $140,115.
  • Decibel Therapeutics peak revenue was $8.5M in 2024.

On this page

Peak revenue
$8.5M (2024)
Company peak revenue
Revenue / employee
$140,115
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$8.5M (2024)
Company peak revenue
Revenue / employee
$140,115
Company revenue / employee

Decibel Therapeutics financing

Decibel Therapeutics received early financing of $52.0M on 2015-10-15.

SeriesRound sizeDate
Series A$52M10/2015
Series C$55M06/2018
Series D$82.2M11/2020

Decibel Therapeutics investors

InvestorsSecurity type
SR OneSeries A
Third Rock VenturesSeries A
Schroder AdveqSeries C
SR OneSeries C
Regeneron Pharmaceuticals Inc.Series C
S-Cubed CapitalSeries C
The Longevity FundSeries C
Bessemer Venture PartnersSeries C
Third Rock VenturesSeries C
Foresite CapitalSeries C
GVSeries C
SR OneSeries D
S-Cubed CapitalSeries D
Sobrato CapitalSeries D
Third Rock VenturesSeries D
OrbiMed AdvisorsSeries D
Foresite CapitalSeries D
Janus Henderson InvestorsSeries D
GVSeries D
Samsara BioCapitalSeries D
Casdin CapitalSeries D
BlackRock, Inc.Series D
Surveyor CapitalSeries D

Decibel Therapeutics revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Decibel Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Decibel Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Decibel Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Decibel Therapeutics. The data presented on this page does not represent the view of Decibel Therapeutics and its employees or that of Zippia.

Decibel Therapeutics may also be known as or be related to Decibel Therapeutics, Decibel Therapeutics Inc and Decibel Therapeutics, Inc.